Skip to Main Content

1,100

Views

0

CrossRef citations to date

0

Altmetric

Influenza

Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season

Marina Amaral de Avila Machadoa Epidemiology & Benefit-Risk, Sanofi, Toronto, CanadaCorrespondence[email protected]
View further author information

,

Sonja Gandhi-Bangaa Epidemiology & Benefit-Risk, Sanofi, Toronto, CanadaView further author information

,

Sophie Gallob Medical Operations, Sanofi, Lyon, FranceView further author information

,

Tathyana Giannotti Cousseauc Patient Safety and Pharmacovigilance, Sanofi, Sao Paulo, BrazilView further author information

,

Reddappa Maniganahally Byrareddyd Patient Safety and Pharmacovigilance, Sanofi, Bangalore, IndiaView further author information

,

Markku Nissiläe Terveystalo Biobank and Clinical Research, Turku, FinlandView further author information

,

Jörg Schellingf Department of Medicine IV, LMU University Hospital, Munich, GermanyView further author information

&

Celine Monfredog Biostatistical Sciences, Sanofi, Marcy l’Etoile, FranceView further author information